The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis

Journal of Dermatological Science

Volumn 17, Issue 1, 1998, Pages 1-7

  Yuspa, Stuart H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EGF receptor; Fos; Protein kinase C; Skin cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1;

CELL PROLIFERATION; GENE CONTROL; GENE MUTATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; PAPILLOMA; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 0032076149     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(97)00071-6     Document Type: Review

References (30)

1. Yuspa SH The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - 33rd G.H.A. Clowes Memorial Award Lecture. Cancer Res. 54:1994;1178-1189.
2. DiGiovanni J Multistage carcinogenesis in mouse skin. Pharmacol Ther. 54:1992;63-128.
3. Yuspa SH, Shields PG Etiology of cancer: chemical factors. DeVita VT, Hellman S, Rosenberg SA Cancer Principles of Oncology. 5th:1997;185-202 Lippincott-Raven, Philadelphia.
4. Nischt R, Roop DR, Mehrel T et al. Aberrant expression during two-stage mouse skin carcinogenesis of type I 47-kDa Keratin, K13, normally associated with terminal differentiation of internal stratified epithelia. Mol Carcinog. 1:1988;96-108.
5. Aldaz CM, Conti CJ, Larcher F et al. Sequential development of aneuploidy, keratin modification and gamma-glutamyltransferase expression in mouse skin papillomas. Cancer Res. 48:1988;3253-3257.
6. Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH The suprabasal expression of α6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 53:1993;4803-4810.
7. Tennenbaum T, Yuspa SH, Grover A et al. Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Res. 52:1992;2966-2976.
8. Glick AB, Kulkarni AB, Tennenbaum T et al. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA. 90:1993;6076-6080.
9. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res. 55:1995;2774-2782.
10. Aldaz CM, Trono D, Larcher F, Slaga TJ, Conti CJ Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog. 2:1989;22-26.
11. Ruggeri B, Caamano J, Goodrow T et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res. 51:1991;6615-6621.
12. Domann FE Jr, Levy JP, Finch JS, Bowden GT Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog. 9:1994;61-66.
13. Lee E, Yuspa SH. Changes in inositol phosphate metabolism are associated with terminal differentiation and neoplasia in mouse keratinocytes. Carcinogenesis. 12:1991;1651-1658.
14. Lee E, Punnonen K, Cheng C, Glick A, Dlugosz A, Yuspa SH Analysis of phospholipid metabolism in murine keratinocytes transformed by the v-ras oncogene: relationship of phosphatidylinositol turnover and cytokine stimulation to the transformed phenotype. Carcinogenesis. 13:1992;2367-2373.
15. Ha genes are mediated by protein kinase C-α Cancer Res. 54:1994;6413-6420.
16. Lee YS, Dlugosz AA, McKay R, Dean NM, Yuspa SH Definition by specific antisense oligonucleotides of a role for protein kinase Cα in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes. Mol Carcinog. 18:1997;44-53.
17. k) gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiate by calcium. J Invest Dermatol. 102:1994;409-414.
18. Dlugosz AA, Yuspa SH Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro. Cancer Res. 51:1991;4677-4684.
19. Ha gene in murine keratinoctyes induces tyrosine phosphorylation and reduced activity of protein kinase Cδ J Biol Chem. 268:1993;26079-26081.
20. Denning MF, Dlugosz AA, Threadgill DW, Magnuson T, Yuspa SH Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase Cδ J Biol Chem. 271:1996;5325-5331.
21. Threadgill DW, Dlugosz AA, Hansen LA et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-234.
22. Ha oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res. 57:1997;3180-3188.
23. Hennings H, Shores R, Wenk ML, Spangler EF, Tarone R, Yuspa SH Malignant conversion of mouse skin tumors is increased by tumor initiators and unaffected by tumor promoters. Nature. 304:1983;67-69.
24. Greenhalgh DA, Yuspa SH Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene. Mol Carcinog. 1:1988;134-143.
25. Greenhalgh DA, Welty DJ, Player A, Yuspa SH Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinomas. Proc Natl Acad Sci USA. 87:1990;643-647.
26. Saez E, Rutberg SE, Mueller E et al. c-fos is required for malignant progression of skin tumors. Cell. 82:1995;721-732.
27. Rutberg SE, Lee EJ, Hansen AB, Glick AB, Yuspa SH. Identification of differentially expressed genes in chemically-induced skin tumors. Mol Carcinog. 20:1997;88-98.
28. Stanwell C, Denning MF, Rutberg SE, Cheng C, Yuspa SH, Dlugosz AA Staurosporine induces a sequential program of mouse keratinocyte terminal differentiation through activation of PKC isozymes. J Invest Dermatol. 106:1996;482-489.
29. Strickland JE, Dlugosz AA, Hennings H, Yuspa SH. Inhibition of tumor formation from grafted murine papilloma cells by treatment of grafts with staurosporine, an inducer of squamous differentiation. Carcinogenesis. 14:1993;205-209.
30. Stanwell C, Dlugosz AA, Yuspa SH Staurosporine induces a complete program of terminal differentiation in neoplastic mouse keratinocytes via activation of protein kinase C. Carcinogenesis. 17:1996;1259-1265.